RxDoctor Payments Data

Laurence Sands, MD

Colon & Rectal Surgery · Miami, FLNPI 1609832922

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (42.6%), education and consulting fees — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 78.6% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $21,632 and has fallen 99.9% since, to $20 in 2025.

$46,910in general payments, 2019–2025

Across 79 payments — averaging $593.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$37K
  • Takeda Pharmaceuticals U.S.A., Inc.$3K
  • Baudax Bio Inc.$3K
  • Covidien LP$1K
  • Medtronic$1K
  • Johnson & Johnson$523
  • plus $919 from 9 others

What the payments were for

  • Consulting fees$8,48318%
  • Speaking & faculty fees$20,00043%
  • Travel & lodging$3,1747%
  • Food & beverage$3,2407%
  • Education$12,00026%
  • Gifts$140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$46,910 in reported general payments places this provider in the 85th percentile of 157 colon & rectal surgery providers in Florida.

See all colon & rectal surgery providers in Florida

Medicare billing

Part B allowed, 2024
$46,092
Medicare patients
158
Services billed
255

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClenpiqSod Picosulf/Mag Ox/Citric Ac11$1,903
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl38$485
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg13$239
Metronidazole12$20

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →